Success Metrics

Clinical Success Rate
78.3%

Based on 18 completed trials

Completion Rate
78%(18/23)
Active Trials
2(6%)
Results Posted
22%(4 trials)
Terminated
5(14%)

Phase Distribution

Ph phase_1
2
6%
Ph phase_2
5
14%
Ph phase_4
5
14%
Ph early_phase_1
1
3%
Ph phase_3
7
20%
Ph not_applicable
8
23%

Phase Distribution

3

Early Stage

5

Mid Stage

12

Late Stage

Phase Distribution28 total trials
Early Phase 1First-in-human
1(3.6%)
Phase 1Safety & dosage
2(7.1%)
Phase 2Efficacy & side effects
5(17.9%)
Phase 3Large-scale testing
7(25.0%)
Phase 4Post-market surveillance
5(17.9%)
N/ANon-phased studies
8(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

18 of 24 finished

Non-Completion Rate

25.0%

6 ended early

Currently Active

2

trials recruiting

Total Trials

35

all time

Status Distribution
Active(2)
Completed(18)
Terminated(6)
Other(9)

Detailed Status

Completed18
unknown9
Terminated5
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
35
Active
2
Success Rate
78.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.6%)
Phase 12 (7.1%)
Phase 25 (17.9%)
Phase 37 (25.0%)
Phase 45 (17.9%)
N/A8 (28.6%)

Trials by Status

recruiting26%
withdrawn13%
completed1851%
terminated514%
unknown926%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT01696734Phase 3

Domperidone in Treating Patients With Gastrointestinal Disorders

Recruiting
NCT04699591Not Applicable

Compassionate Use of Domperidone for Refractory Gastroparesis

Recruiting
NCT02227927

Treatment Use of Domperidone for Gastroparesis

Unknown
NCT03617016Phase 4

Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia

Completed
NCT03810287

The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms

Unknown
NCT02816853Phase 1

Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants

Completed
NCT04024865

Domperidone and Risk of Serious Cardiac Events in Postpartum Women

Completed
NCT02567175

Domperidone Expanded Access Protocol for Patients With Gastrointestinal Disorders

Unknown
NCT02500108

Domperidone and Risk of Sudden Cardiac Death

Completed
NCT05570292Phase 3

Study of Effects of Preoperative Oral Domperidone on Gastric Residual Volume After Clear Fluid Ingestion in Patients Scheduled for Elective Surgeries

Completed
NCT03128398

Use of Domperidone for Treatment of Upper Gastrointestinal Disorders

Unknown
NCT04104867Not Applicable

Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy

Unknown
NCT04583111Phase 4

The Effect of Antiemetics on Bowel Preparation Before Colonoscopy

Unknown
NCT02757534

Domperidone for Chronic Nausea and Vomiting

Unknown
NCT02308137Phase 2

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

Completed
NCT02493049Phase 2

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

Completed
NCT03022201Phase 4

Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease

Completed
NCT02699385Phase 3

A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis

Terminated
NCT03806062Phase 4

EFFECT OF LOW LEVEL LASER THERAPY VERSUS ELECTROACUPUNCTURE ON POSTNATAL SCANTY MILK SECRETION

Completed
NCT03662113Not Applicable

Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
35